Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tartrate-resistant acid phosphatase: gene structure and function

E Fleckenstein1, H G Drexler

  • 1DSMZ-German Collection of Microorganisms and Cell Cultures, Department of Human and Animal Cell Cultures, Braunschweig, Germany.

Leukemia
|January 1, 1997
PubMed
Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cytogenetically cryptic ZMYM2-FLT3 and DIAPH1-PDGFRB gene fusions in myeloid neoplasms with eosinophilia.

Leukemia·2017
Same author

Esterase Isoenzyme Profiles in Acute and Chronic Leukemias.

Leukemia & lymphoma·2016
Same author

Lineage-Specific Monocytic Esterase, a Distinct Marker for Leukemias of Monocytic Origin: Cytochemical, Isoenzymatic and Biochemical Features.

Leukemia & lymphoma·2016
Same author

Acid Phosphatase Isoenzyme Profiles in Acute and Chronic Leukemias.

Leukemia & lymphoma·2016
Same author

Differential expression of TRAP Isoenzyme in B-CLL Cells Treated with Different Inducers.

Leukemia & lymphoma·2016
Same author

Delayed Induction of Proto-Oncogene Expression in B-CLL Cells by Tumor Necrosis Factor.

Leukemia & lymphoma·2016
Same journal

Evolutionary considerations for risk stratification in TP53-variant myeloproliferative neoplasms.

Leukemia·2026
Same journal

Measurable residual disease is not a universally reliable surrogate for progression-free survival in clinical trials of new chronic lymphocytic leukemia therapies.

Leukemia·2026
Same journal

Mantle cell lymphoma artificial intelligence prognostic index using hematoxylin and eosin histology.

Leukemia·2026
Same journal

Redefining light-chain smoldering multiple myeloma: prevalence and progression risk.

Leukemia·2026
Same journal

Decreased TXNRD1 is associated with resistance to tagraxofusp in blastic plasmacytoid dendritic cell neoplasms, as seen in phase II.

Leukemia·2026
Same journal

Retroperitoneal bulk predicts chylothorax in follicular lymphoma-control requires systemic response.

Leukemia·2026
See all related articles